Click here to view next page of this article
Newborn Care and Newborn Infant
Fetal Assessment
Indications for Prenatal Diagnostic Testing for Birth Defects
Cytogenetic Indications
- Advanced maternal age (>35 yrs)
- Previous offspring with chromosome abnormality,
especially trisomy
- Chromosome abnormality in either parent, especially
translocation
- Need to determine fetal sex when there is a family
history of serious X-linked disease
Single gene disorder in a sibling or carrier parent
Multifactorial disorder in first-degree relatives
Routine Assessment of Intrauterine Growth
and Maturation
Document maturity and EDC
- Documentation of fetal heart tones for 30 weeks by
Doppler ultrasound.
- 36 weeks of positive pregnancy test (HCG).
- Ultrasound examination documenting one of following:
- Crown rump length between 6-11 weeks
- Evaluation at 12-20 weeks that confirms clinical
history and physical examination
Assessment of Continued Growth
- Crown rump length, femur length, chest and abdominal
circumference, head circumference
Assessment of Pulmonary Maturity
- Presence of phosphatidylglycerol (PG) indicates
maturity.
- A ratio of lecithin to sphingomyelin (L:S) ratio
>2 is consistent with maturity
- Foam stability index: complete bubble ring indicates
maturity
- Delta optical density 650 >0.15 indicates
maturity
Assessment of Placental Integrity
- Ultrasound evaluation of placenta
and fetus (location, size, morphology)
- Doppler Flow Studies. Assessment of
blood flow velocity in uterus, placenta, cord vessels, and fetal aorta/carotid arteries.
May be useful in conditions of compromised blood flow (eg, IUGR, hypertension, diabetes
mellitus and postmaturity). Elevated systolic:diastolic umbilical artery velocity ratio,
elevated pulsatility index and reduced end-diastolic flow velocity suggest fetal distress.
Periumbilical Blood Sampling (PUBS)
- HCT determination
- Rapid karyotype
- Platelet assessment
- Acid-base assessment
- Biochemical and serologic studies
Intrapartum Assessment
| Testing During
pregnancy |
| Time (week) |
Assessment |
| Initial (as early as possible) |
Hemoglobin or hematocrit measurement Urinalysis, including microscopic examination and infection screen
Blood group and Rh type determinations
Antibody screen
Rubella antibody titer measurement
Syphilis screen
Cervical cytology
Hepatitis B virus screen |
| 8-18 |
Ultrasound Amniocentesis
Chorionic villus sampling
Maternal serum alpha-fetoprotein |
| 26-28 |
Diabetes screening Repeat hemoglobin or hematocrit measurement |
| 28 |
Repeat antibody test for unsensitized Rh-negative
patients Prophylactic
administration of Rho(D) immune globulin |
| 32-36 |
Ultrasound Testing for sexually transmitted disease
Repeat hemoglobin or hematocrit measurement
Culture for Group B streptococcal colonization |